Who owns Brainstorm Cell Therapeutics call?

Tip: Access positions for across all investors

Analyze quarterly positions in Brainstorm Cell Therapeutics call with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Brainstorm Cell Therapeutics call stock

Who bought or sold Brainstorm Cell Therapeutics call this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Simplex Trading 6.2k $1.0k -32% Dec 2023
 View chart